Actively Recruiting
Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2024-07-12
1500
Participants Needed
1
Research Sites
438 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will include patients diagnosed with Arrhythmogenic cardiomyopathy (ACM) in the First Affiliated Hospital of Xi 'an Jiaotong University and other centers, and collect clinical data and biological samples of patients with different ACM phenotypes. Through the establishment of disease cohort and long-term follow-up, to explore the disease characteristics, development law, clinical characteristics, natural course of disease and long-term prognosis of ACM.
CONDITIONS
Official Title
Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years old.
- Diagnosis of ACM confirmed by cardiac ultrasound, electrocardiogram, magnetic resonance angiography, pathological examination, and gene sequencing.
- Patients or their families agree to participate and provide informed consent.
You will not qualify if you...
- Incomplete clinical data.
- Do not agree to participate or refuse to provide informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Xi'an Jiantong University
Xi'an, Shaanxi, China, 710061
Actively Recruiting
Research Team
Y
Yang Yan
CONTACT
G
Guoliang Li
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here